亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台,协助业界发掘知识产权贸易商机,并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权,或是制造商需要购买技术以提高操作效能,又或是知识产权配套服务供应商,你将会从本网站发掘到有用的知识产权贸易资讯。

ANG-2

总结
Angiopoietin-2 predicts the efficacy of angiogenesis inhibitors in colorectal cancer therapy.
技术优势
Ang-2 level as predictive biomarker for angiognese-targeted therapeutical approaches of CRC.
Low pretherapeutic serum Ang-2 levels are associated with: reduced risk of death, increased progression-free survival.
技术应用
Cancer Therapy- Strong diagnostic potential of the predictive biomarker has been demonstrated in pretherapeutic blood samples from colorectal cancer patients vs. healthy controls
详细技术说明
A novel predictive biomarker to help identify the patient population with the most favorable clinical outcome to angiogenesis-targeted treatment in mCRC patients.Experiments revealed that patients with low pretherapeutic Ang-2 serum levels receiving a bevacizumab-containing treatment were associated with a better response rate compared to patients with high pretherapeutic Ang-2 levels
合作类型
Licensing
申请日期
06/09/2010 00:00:00
申请号码
EP20100757580 20100906
分类
- international:
G01N33/68
- cooperative:
G01N33/57419; G01N2333/515; G01N2800/52; G01N2800/56
其他
Patent application
ID号码
2262
国家/地区
德国

欲了解更多信息,请点击 这里
移动设备